Massive 5-Year lupus drug watchdog study completes

NCT ID NCT01729455

Completed Knowledge-focused Sponsor: GlaxoSmithKline Source: ClinicalTrials.gov ↗

Summary

This study followed over 3,100 adults with active lupus for five years to track the safety and effectiveness of the drug Benlysta (belimumab) compared to standard treatments. Participants were either taking Benlysta or other standard lupus medications, and doctors could change treatments as needed during the study. The main goal was to monitor for serious side effects like infections, cancers, and psychiatric events to better understand the long-term risks and benefits of this medication.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

GSK Investigational Site

Birmingham, Alabama, 35294, United States
GSK Investigational Site

Glendale, Arizona, 85304, United States
GSK Investigational Site

Goodyear, Arizona, 85395, United States
GSK Investigational Site

Phoenix, Arizona, 85032, United States
GSK Investigational Site

Phoenix, Arizona, 85037, United States
GSK Investigational Site

Prescott, Arizona, 86305, United States
GSK Investigational Site

Sun City, Arizona, 85351, United States
GSK Investigational Site

Tucson, Arizona, 85704, United States
GSK Investigational Site

Tucson, Arizona, 85712, United States
GSK Investigational Site

Bakersfield, California, 93301, United States
GSK Investigational Site

La Mesa, California, 92020, United States
GSK Investigational Site

Lakewood, California, 90712, United States
GSK Investigational Site

Loma Linda, California, 92354, United States
GSK Investigational Site

Los Angeles, California, 90033, United States
GSK Investigational Site

Los Angeles, California, 90048, United States
GSK Investigational Site

Los Angeles, California, 90095, United States
GSK Investigational Site

Murrieta, California, 92563, United States
GSK Investigational Site

Pomona, California, 91767, United States
GSK Investigational Site

Upland, California, 91786, United States
GSK Investigational Site

West Hills, California, 91307, United States
GSK Investigational Site

Danbury, Connecticut, 06810, United States
GSK Investigational Site

New Haven, Connecticut, 06520, United States
GSK Investigational Site

Orangeburg, Connecticut, 06518, United States
GSK Investigational Site

Brandon, Florida, 33511, United States
GSK Investigational Site

Clearwater, Florida, 33759, United States
GSK Investigational Site

Fort Lauderdale, Florida, 33309, United States
GSK Investigational Site

Jupiter, Florida, 33458, United States
GSK Investigational Site

Largo, Florida, 33770, United States
GSK Investigational Site

Miami, Florida, 33126, United States
GSK Investigational Site

Miami, Florida, 33136, United States
GSK Investigational Site

Palm Harbor, Florida, 34684, United States
GSK Investigational Site

Pembroke Pines, Florida, 33026, United States
GSK Investigational Site

Pensacola, Florida, 32514, United States
GSK Investigational Site

Plantation, Florida, 33324, United States
GSK Investigational Site

Atlanta, Georgia, 30303, United States
GSK Investigational Site

Gainesville, Georgia, 30501, United States
GSK Investigational Site

Meridian, Idaho, 83642, United States
GSK Investigational Site

Chicago, Illinois, 60611, United States
GSK Investigational Site

Chicago, Illinois, 60612, United States
GSK Investigational Site

Morton Grove, Illinois, 60053, United States
GSK Investigational Site

South Bend, Indiana, 46601, United States
GSK Investigational Site

Baton Rouge, Louisiana, 70809, United States
GSK Investigational Site

Shreveport, Louisiana, 71103, United States
GSK Investigational Site

Baltimore, Maryland, 21286, United States
GSK Investigational Site

Springfield, Massachusetts, 01107, United States
GSK Investigational Site

Ann Arbor, Michigan, 48109-5542, United States
GSK Investigational Site

Ann Arbor, Michigan, 48917, United States
GSK Investigational Site

Detroit, Michigan, 48202, United States
GSK Investigational Site

Eagan, Minnesota, 55121, United States
GSK Investigational Site

Edina, Minnesota, 55435, United States
GSK Investigational Site

Jackson, Mississippi, 39216, United States
GSK Investigational Site

Tupelo, Mississippi, 38801, United States
GSK Investigational Site

St Louis, Missouri, 63110, United States
GSK Investigational Site

St Louis, Missouri, 63117, United States
GSK Investigational Site

St Louis, Missouri, 63132, United States
GSK Investigational Site

Omaha, Nebraska, 68198-7680, United States
GSK Investigational Site

Henderson, Nevada, 89052, United States
GSK Investigational Site

Summit, New Jersey, 07901, United States
GSK Investigational Site

Teaneck, New Jersey, 07666, United States
GSK Investigational Site

Voorhees Township, New Jersey, 08103, United States
GSK Investigational Site

Manhasset, New York, 11030, United States
GSK Investigational Site

Mineola, New York, 11501, United States
GSK Investigational Site

New York, New York, 10016, United States
GSK Investigational Site

New York, New York, 10021, United States
GSK Investigational Site

Roslyn, New York, 11576, United States
GSK Investigational Site

Smithtown, New York, 11787, United States
GSK Investigational Site

The Bronx, New York, 10461, United States
GSK Investigational Site

Charlotte, North Carolina, 28204, United States
GSK Investigational Site

Charlotte, North Carolina, 28207, United States
GSK Investigational Site

Greensboro, North Carolina, 27405, United States
GSK Investigational Site

New Bern, North Carolina, 28562, United States
GSK Investigational Site

Raleigh, North Carolina, 27617, United States
GSK Investigational Site

Rocky Mount, North Carolina, 27804, United States
GSK Investigational Site

Winston-Salem, North Carolina, 27157, United States
GSK Investigational Site

Columbus, Ohio, 43203, United States
GSK Investigational Site

Toledo, Ohio, 43614, United States
GSK Investigational Site

Edmond, Oklahoma, 73013, United States
GSK Investigational Site

Oklahoma City, Oklahoma, 73103, United States
GSK Investigational Site

Oklahoma City, Oklahoma, 73104, United States
GSK Investigational Site

Oklahoma City6, Oklahoma, 73103, United States
GSK Investigational Site

Tulsa, Oklahoma, 74104, United States
GSK Investigational Site

Duncansville, Pennsylvania, 16635, United States
GSK Investigational Site

Philadelphia, Pennsylvania, 19107, United States
GSK Investigational Site

Pittsburgh, Pennsylvania, 15224, United States
GSK Investigational Site

Charleston, South Carolina, 29406, United States
GSK Investigational Site

Charleston, South Carolina, 29425, United States
GSK Investigational Site

Hixson, Tennessee, 37343-7908, United States
GSK Investigational Site

Nashville, Tennessee, 37203, United States
GSK Investigational Site

Allen, Texas, 75013, United States
GSK Investigational Site

Arlington, Texas, 22205-3606, United States
GSK Investigational Site

Houston, Texas, 77004, United States
GSK Investigational Site

Houston, Texas, 77034, United States
GSK Investigational Site

Nassau Bay, Texas, 77058, United States
GSK Investigational Site

Round Rock, Texas, 78665, United States
GSK Investigational Site

San Marcos, Texas, 78666, United States
GSK Investigational Site

The Woodlands, Texas, 77382, United States
GSK Investigational Site

Danville, Virginia, 24541, United States
GSK Investigational Site

Norfolk, Virginia, 23502, United States
GSK Investigational Site

Roanoke, Virginia, 24016, United States
GSK Investigational Site

Seattle, Washington, 98133, United States
GSK Investigational Site

Glendale, Wisconsin, 91204, United States
GSK Investigational Site

Manitowoc, Wisconsin, 54221-1450, United States
GSK Investigational Site

Buenos Aires, C1280AEB, Argentina
GSK Investigational Site

Ciudad autOnoma de Bueno, C1426AAL, Argentina
GSK Investigational Site

Paraná, 3103, Argentina
GSK Investigational Site

Graz, 8036, Austria
GSK Investigational Site

Linz, 4021, Austria
GSK Investigational Site

Salzburg, A-5020, Austria
GSK Investigational Site

Vienna, A-1100, Austria
GSK Investigational Site

Leuven, 3000, Belgium
GSK Investigational Site

Mississauga, Ontario, L5M 2V8, Canada
GSK Investigational Site

Toronto, Ontario, M5T 2S8, Canada
GSK Investigational Site

Montreal, Quebec, H3G 1A4, Canada
GSK Investigational Site

Québec, Quebec, G1V 2L9, Canada
GSK Investigational Site

Sherbrooke, Quebec, J1G 2E8, Canada
GSK Investigational Site

Bondy, 93140, France
GSK Investigational Site

Lille, 59037, France
GSK Investigational Site

Paris, 75571, France
GSK Investigational Site

Strasbourg, 67098, France
GSK Investigational Site

Bad Bramstedt, 24576, Germany
GSK Investigational Site

Bad Nauheim, 61231, Germany
GSK Investigational Site

Cologne, 51149, Germany
GSK Investigational Site

Dresden, 01067, Germany
GSK Investigational Site

Düsseldorf, 40225, Germany
GSK Investigational Site

Elmshorn, 25335, Germany
GSK Investigational Site

Halle, 06120, Germany
GSK Investigational Site

Hamburg, 22767, Germany
GSK Investigational Site

Heidelberg, 69121, Germany
GSK Investigational Site

Jena, 07740, Germany
GSK Investigational Site

Kiel, 23538, Germany
GSK Investigational Site

Kiel, 24105, Germany
GSK Investigational Site

Leipzig, 04129, Germany
GSK Investigational Site

Mainz, 55131, Germany
GSK Investigational Site

Püttlingen, 66346, Germany
GSK Investigational Site

Stuttgart, 70376, Germany
GSK Investigational Site

Ashkelon, 78278, Israel
GSK Investigational Site

Haifa, 31048, Israel
GSK Investigational Site

Haifa, 31096, Israel
GSK Investigational Site

Jerusalem, 91120, Israel
GSK Investigational Site

Nahariya, 22100, Israel
GSK Investigational Site

Petah Tikva, 49100, Israel
GSK Investigational Site

Ramat Gan, 52621, Israel
GSK Investigational Site

Rehovot, 76100, Israel
GSK Investigational Site

Tel Aviv, 64239, Israel
GSK Investigational Site

Brescia, 25125, Italy
GSK Investigational Site

Milan, 20122, Italy
GSK Investigational Site

Milan, 20132, Italy
GSK Investigational Site

Milan, 20157, Italy
GSK Investigational Site

Padua, 35128, Italy
GSK Investigational Site

Pisa, 56126, Italy
GSK Investigational Site

Roma, 00161, Italy
GSK Investigational Site

Roma, 00168, Italy
GSK Investigational Site

Siena, 53100, Italy
GSK Investigational Site

Udine, 33100, Italy
GSK Investigational Site

Lisbon, 1069-166, Portugal
GSK Investigational Site

Bratislava, 826 06, Slovakia
GSK Investigational Site

Košice, 040 11, Slovakia
GSK Investigational Site

Košice, 97401, Slovakia
GSK Investigational Site

Piešťany, 921 01, Slovakia
GSK Investigational Site

Piešťany, 921 12, Slovakia
GSK Investigational Site

A Coruña, 15006, Spain
GSK Investigational Site

Alicante, 03010, Spain
GSK Investigational Site

BaracaldoVizcaya, 48903, Spain
GSK Investigational Site

Barcelona, 08035, Spain
GSK Investigational Site

Barcelona, 08907, Spain
GSK Investigational Site

Getafe, 28905, Spain
GSK Investigational Site

Las Palmas, 35020, Spain
GSK Investigational Site

Madrid, 28007, Spain
GSK Investigational Site

Madrid, 28041, Spain
GSK Investigational Site

Madrid, 28222, Spain
GSK Investigational Site

Murcia, 30120, Spain
GSK Investigational Site

Santander, 39008, Spain
GSK Investigational Site

Toledo, 45111, Spain
GSK Investigational Site

Valencia, 46017, Spain
GSK Investigational Site

Valencia, 46026, Spain
GSK Investigational Site

Valladolid, 47012, Spain
GSK Investigational Site

VigoPontevedra, 36200, Spain
GSK Investigational Site

Villajoyosa, 3570, Spain
GSK Investigational Site

Stockholm, SE-171 76, Sweden

Conditions

Explore the condition pages connected to this study.

SYSTEMIC LUPUS ERYTHEMATOSUS